3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The threat of veterinary medicinal products and biocides on pollinators: A One Health perspective

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The One Health approach acknowledges that human health is firmly linked to animal and environmental health. It involves using animals such as bees and other pollinators as sentinels for environmental contamination or biological indicators. Beekeepers noticed intoxications of apiaries located in the vicinity of sheep and cattle farms, which led to the suspicion of bees' intoxication by the products used for livestock: veterinary medicinal products (VMPs) and Biocides, confirmed by laboratory analysis. We review the legal context of VMPs and Biocidal products considering Europe as a case study, and identify shortcomings at the environmental level. We describe the possible ways these products could intoxicate bees in the vicinity of livestock farms. We also illustrate the way they may impact non-target species. The cases of ivermectin and abamectin as VMPs, deltamethrin and permethrin as Biocides are considered as case studies. We show bees can be exposed to new and unrecognized routes of exposure to these chemicals, and demonstrate that their application in livestock farming can affect the survival of pollinators, such as bees. We conclude that: (1) figures on the marketing/use of these chemicals should be harmonized, centralized and publicly available, (2) research should be devoted to clarifying how pollinators are exposed to VMPs and Biocides, (3) toxicity studies on bees should be carried out, and (4) pollinators should be considered as non-targeted species concerning the environmental risk assessment before their marketing authorization. We propose the term “Multi-use substances” for active ingredients with versatile use.

          Graphical abstract

          Highlights

          • We evaluate the impact that VMPs and Biocides have on bees using the One Health concept.

          • We show that VMPs and Biocides involve health risks to pollinators, which remain unconsidered.

          • Lack of data and knowledge gaps should be filled regarding exposure and toxicity to pollinators of VPMs and Biocides

          • Bees ought to be included in environmental risk assessment of VMPs and Biocides

          • Term “Multi-use substances”, for referring to a product with versatile usage: VMPs, Biocides, and pesticides.

          Related collections

          Most cited references104

          • Record: found
          • Abstract: not found
          • Article: not found

          Economic valuation of the vulnerability of world agriculture confronted with pollinator decline

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Guidance on the risk assessment of plant protection products on bees (Apis mellifera,Bombusspp. and solitary bees)

            (2013)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effects of neonicotinoids and fipronil on non-target invertebrates

              We assessed the state of knowledge regarding the effects of large-scale pollution with neonicotinoid insecticides and fipronil on non-target invertebrate species of terrestrial, freshwater and marine environments. A large section of the assessment is dedicated to the state of knowledge on sublethal effects on honeybees (Apis mellifera) because this important pollinator is the most studied non-target invertebrate species. Lepidoptera (butterflies and moths), Lumbricidae (earthworms), Apoidae sensu lato (bumblebees, solitary bees) and the section “other invertebrates” review available studies on the other terrestrial species. The sections on freshwater and marine species are rather short as little is known so far about the impact of neonicotinoid insecticides and fipronil on the diverse invertebrate fauna of these widely exposed habitats. For terrestrial and aquatic invertebrate species, the known effects of neonicotinoid pesticides and fipronil are described ranging from organismal toxicology and behavioural effects to population-level effects. For earthworms, freshwater and marine species, the relation of findings to regulatory risk assessment is described. Neonicotinoid insecticides exhibit very high toxicity to a wide range of invertebrates, particularly insects, and field-realistic exposure is likely to result in both lethal and a broad range of important sublethal impacts. There is a major knowledge gap regarding impacts on the grand majority of invertebrates, many of which perform essential roles enabling healthy ecosystem functioning. The data on the few non-target species on which field tests have been performed are limited by major flaws in the outdated test protocols. Despite large knowledge gaps and uncertainties, enough knowledge exists to conclude that existing levels of pollution with neonicotinoids and fipronil resulting from presently authorized uses frequently exceed the lowest observed adverse effect concentrations and are thus likely to have large-scale and wide ranging negative biological and ecological impacts on a wide range of non-target invertebrates in terrestrial, aquatic, marine and benthic habitats.
                Bookmark

                Author and article information

                Contributors
                Journal
                One Health
                One Health
                One Health
                Elsevier
                2352-7714
                18 March 2021
                June 2021
                18 March 2021
                : 12
                : 100237
                Affiliations
                [a ]Catholic University of Louvain, Faculty of bioscience engineering, Place Croix du Sud 2, 1348 Ottignies-Louvain-la-Neuve, Belgium
                [b ]Beekeeping Center of Research and Information (CARI asbl), BeeLife European Beekeeping Coordination, Place Croix du Sud 1, 1348 Louvain la Neuve, Belgium
                [c ]Sorbonne University, CNRS, IRD, INRAE, University of Paris, UPEC, Institute of Ecology and Environmental Sciences-Paris (IEES-Paris), 75005 Paris, France
                [d ]Montpellier Fédération Nationale des Organisations Sanitaires Apicoles Départementales (FNOSAD), 41 Rue Pernety, 75014 Paris, France
                [e ]Centre National de la Recherche Scientifique (CNRS), Centre de biophysique moléculaire, 45071 Orléans Cedex 02, France
                Author notes
                [* ]Corresponding author. simon@ 123456cari.be
                [1]

                Co-first author

                Article
                S2352-7714(21)00027-6 100237
                10.1016/j.onehlt.2021.100237
                8022246
                33851001
                d47e5bc1-ff9c-40f2-bfc6-0619ec6c6827
                © 2021 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 16 December 2020
                : 11 March 2021
                : 15 March 2021
                Categories
                Research Paper

                pesticide,livestock,bees,ecotoxicology,environmental health,risk assessment,multi-use substances,btv, bluetongue virus,echa, european chemical agency,eia, environmental impact assessment,ema, environmental medicine agency,era, environmental risk assessment,ma, market authorisation,pec, predicted environmental concentration,pnec, predicted no effect concentration,vmps, veterinary medicinal products,sps, synthetic pyrethroids,rq, risk quotient,vich, international cooperation on harmonization of technical requirements for registration of veterinary medicinal products.

                Comments

                Comment on this article